Skip to content

Drug interactions

Idecabtagene vicleucel + Infliximab

Severity: Moderate

Idecabtagene vicleucel and Infliximab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Immunosuppressants such as infliximab could blunt CAR-T cell expansion and efficacy. Patients are also already at high infection risk after CAR-T therapy, so added immunosuppression is of concern.

What this interaction means in plain words

Idecabtagene vicleucel and Infliximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Idecabtagene vicleucel belongs to Oncology; Infliximab belongs to Musculoskeletal.

Evidence level: Low

Why it happens

TNF blockade may impair CAR-T activity and adds to immunosuppression.

What to do

Avoid infliximab around leukapheresis and CAR-T infusion unless essential. Monitor for infection and treatment response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idecabtagene vicleucel and Infliximab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idecabtagene vicleucel with Infliximab?

MediHelp rates the interaction as moderate. Idecabtagene vicleucel and Infliximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Immunosuppressants such as infliximab could blunt CAR-T cell expansion and efficacy. Patients are also already at high infection risk after CAR-T therapy, so added immunosuppression is of concern.

How serious is the interaction between Idecabtagene vicleucel and Infliximab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid infliximab around leukapheresis and CAR-T infusion unless essential. Monitor for infection and treatment response.

What other medicines interact with Infliximab?

MediHelp also lists interactions of Infliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Infliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in